[300+ Pages Report] The global gastric space-occupying devices market was valued at US$ 197.5 Mn in 2021. As per the report, demand in the market will increase at an impressive 13.7% CAGR over the forecast period, with the market size reaching US$ 810.8 Mn by 2032. Gastric balloons are leading the market in terms of product with a market share of around 97.0% in 2021.
| Attributes | Key Statistics |
|---|---|
| Gastric Space-Occupying Devices Market Base Year Value (2021) | US$ 197.5 million |
| Estimated Market Size (2022) | US$ 224.6 million |
| Projected Market Valuation (2032) | US$ 810.8 million |
| Value-based CAGR (2022-2032) | 13.7% |
| Market Share of Top 5 Countries | 52.0% |
Despite advancements in lifestyle interventions, obesity management pharmacotherapies and metabolic or bariatric surgery, the healthcare burden due to obesity continues to increase. Thus, endoscopic bariatric therapies (EBTs) are gaining traction as they are effective, safe, reversible, and economical. These therapies allow treatment of individuals that are unable to undergo bariatric surgery. Among the endoscopic modalities, the employment of a space-occupying device is one of the most ancient and effective therapies.
Considering the large market size of obesity treatment and the small percentage of patients treated with drugs or bariatric surgery, gastric space-occupying devices can play a major role in the management of obesity.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for gastric space-occupying devices was approximately 5.5% of the overall US$ 3.6 Bn worth weight loss management market in 2021. Sales of gastric space-occupying devices increased at a CAGR of 5.4% between 2017 to 2021, owing to high demand for minimally invasive surgeries for obesity management.
The global prevalence of obesity almost tripled between 1975 and 2020. In 2020, globally over 2 billion adults were overweight (body mass index (BMI) > 25) and more than 600 million were obese (BMI > 30). In Europe, nearly 50% of the population is overweight and more than 30% is obese.
Obesity, along with its obesity-related disorders such as diabetes, hypertension, non-alcoholic fatty liver disease, hyperlipidemia, and obstructive sleep apnea has become a global burden. If the incidence of obesity continues on its current trajectory, nearly half of the adult population will have obesity issues by 2030.
Although widely accessible for managing obesity, traditional therapeutic modalities including lifestyle change and dietary counselling are less effective. Contrarily, patients who have not improved after receiving more conventional medical care but prefer not to undergo surgery can consider anti-obesity medical devices.
Gastric space-occupying devices are positioned to bridge the gap between more conservative treatments and more aggressive interventions such as bariatric surgery. Gastric space-occupying device therapy is more advantageous when compared to bariatric surgery, as they are less invasive in nature, and promote ease of performance, and reversibility.
These devices are available upon prescription or as over-the-counter products. Thus, several advantages of these medical devices are expected to increase the demand for gastric space-occupying devices during the forecast period.
Owing to the rising prevalence of obesity and growing demand for minimally invasive surgical procedures in obesity treatment, demand in the global gastric space-occupying devices market is anticipated to grow at a CAGR of 13.7% during the forecast period.
Endoscopic bariatric therapies can be a sustainable treatment option for obesity management. Along with safety and efficacy of data, these therapies will be the most successful treatment in the next few years. Several researchers are focusing on the tandem and progressive use of a combination of space-occupying endoscopic devices and weight loss drug treatment to enhance the stability of weight loss with a long-lasting effect on obesity and associated diseases.
The global healthcare burden due to obesity accounts for around US$ 2 trillion yearly or around 2.8% of GDP. This is approximately equal to the worldwide effect of smoking or armed violence, war, and terrorism (McKinsey Global Institute, 2014). The tax on obesity in healthcare systems alone is between 2% and 7% of all healthcare expenditures in developed countries. These figures indicate that obesity is considered one of the top 3 community problems.
To manage the obesity-related healthcare burden, governments are taking initiatives to create awareness among people which will create opportunities for key players to be actively involved in the development and launch of cost-effective solutions for obesity management.
Principal Consultant
The key challenges in the development of gastric space-occupying devices are the lack of specific regulatory guidance and inconsistencies in the time and cost of approval processes in different countries.
Awareness is also an obstacle in the adoption of gastric space-occupying devices. In the realm of weight-loss management, they are still relatively unknown to a large part of the population.
Additionally, increasing product recalls are also hampering growth to an extent. Several gastric space-occupying devices have been withdrawn by manufacturers from the market in the U.S. after approval by the FDA (e.g., ReShape integrated dual balloon system and Garren gastric bubble.
The use of gastric space-occupying devices is a relatively new technology for weight-loss treatment. Lack of reimbursement for such procedures in most countries can potentially hinder growth. Mostly, health insurance plans have fitness criteria of BMI of 35 or 45 for providing reimbursement for obesity management treatments. Though, patients are eligible for gastric space-occupying devices treatment at BMI 27 and are thus not reimbursed.
Furthermore, most countries treat gastric space-occupying devices as a primary procedure which is in the investigational stage. The therapy is not included in the reimbursement policies of Medicaid (CMC) and Medicare in the U.S. with a similar scenario existing in Australia, Canada, and other countries in Asia and Europe.
“High Incidence of Obesity Related Disorders in U.S. is Spurring Demand for Gastric Space-Occupying Devices”
The U.S. dominated the North America market in 2021, holding about 83.3% of the market share. As per the report, the trend is expected to continue over the assessment period increasing demand for minimally invasive surgeries for obesity management
In 2017, the American Society for Metabolic and Bariatric Surgery (ASMBS) included gastric space-occupying devices in the list of procedures and devices approved by the society as a treatment option. The sanction and endorsements of this treatment by the ASMBS are expected to increase the adoption of gastric space-occupying devices in the U.S.
“Rapid Adoption of Anti-Obesity Medica Devices in the U.K. Will Boost Sales”
Demand in the U.K. market is set to increase at a CAGR of 12.5% in the Europe gastric space-occupying devices market during the forecast period.
Non-invasiveness often favoured by both clinicians and patients in the U.K. Similarly, innovation and techniques to challenge obesity are increasing in the country, and several key players are competing by innovating.
High adoption of obesity management treatments, and the availability of skilled professionals are some of the key factors contributing to the growth in the market.
“Rising Preference for Minimally Invasive Surgeries in China Will Fuel Sales”
Sales in the China market are expected to increase at a 14.4% CAGR over the assessment period.
In the past four years, the rates of obesity in China have rapidly increased, along with economic growth, urbanisation, and globalisation. According to the Chinese Residents Chronic Diseases and Nutrition report, in China over 50% of adults and 20% of school-age children were found to be obese in 2020. This figure indicates the need for obesity management and increased demand for EBT, which is ultimately fueling demand for gastric space-occupying devices.
Furthermore, several government initiatives to create awareness are also supplementing the growth in the market. For instane, The Obesity Prevention and Control Society of Chinese Nutrition Society (OPCS-CNS) has collaborated with other government bodies to carry out a series of activities to inspire individuals to pay attention to the obesity problem and take more practical actions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Demand for Gastric Balloons Will Gain Momentum”
Based on product type, sales of gastric balloons held the highest market share of about 97.0% in the market in 2021 and are expected to grow at a CAGR of 13.67% over the forecast period. Through endoscopy, gastric balloons are inserted into the body and offer weight loss of up to 7 to 8 pounds.
An average 7-pound weight loss is possible with the Orbera gastric balloon. The Obalon gastric balloon, on the other hand, offers an average of 7.4 pounds, or 3.42 percent of their total body weight.
“Adoption of Obesity Management Pharmacotherapies in Hospitals Will Remain High”
Hospitals held the highest share of 59.0% in 2021. Rising prevalence of obesity, along with growing healthcare investments across the globe, and government policies for the execution of superior patient care are driving sales in this segment.
Similarly, new clinical trials conducted in multi-speciality hospitals will provide opportunities to the patients to explore new experimental therapies, thus boosting demand.
The gastric space-occupying devices market is fairly consolidated and led by few market players. These players are focusing on product development and expansion strategies to gain traction in the market. For instance:
| Attribute | Details |
|---|---|
| Estimated Market Size (2022) | US$ 224.6 million |
| Projected Market Valuation (2032) | US$ 810.8 million |
| Value-based CAGR (2022-2032) | 13.7% |
| Forecast Period | 2017-2021 |
| Historical Data Available for | 2022-2032 |
| Market Analysis | US$ million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, the UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, North Africa, and South Africa |
| Key Market Segments Covered | Product, End User, and Region |
| Key Companies Profiled |
|
The global gastric space-occupying devices market is worth US$ 197.5 Mn in 2021 and is set to expand 3.6X over the next ten years.
The gastric space-occupying devices market is expected to reach US$ 810.8 Mn by the end of 2032, with sales revenue expected to register a 13.7% CAGR.
The rising prevalence of obesity, growing preference for minimally invasive therapies, and the increasing need for gastric space-occupying devices in obesity management are some of the key trends in this market.
U.S., U.K., Germany, China, and Japan are expected to drive demand for the gastric space-occupying devices industry.
North America is one of the key markets for gastric space-occupying devices, with the U.S. accounting for about 83.3% of the North American gastric space-occupying devices market in the year 2021.
Demand for gastric space-occupying devices in Europe is expected to register a growth of 12.99% over the next ten years.
The U.S., U.K., and China are the key producers of gastric space-occupying devices.
Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., Allurion Technologies, Inc., Helioscopie, Endalis, MEDSIL, ReShape Medical, Inc., Lexel Medical, and Scientific Intake, is some of the key players in the gastric space-occupying devices industry.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions & Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Innovation / Development Trends 4. Key Success Factors 4.1. Key Promotional Strategies, By Key Player 4.2. Product Adoption/Usage Analysis 4.3. Technology Assessment 4.4. Regulatory Scenario 4.5. Value Chain Analysis 4.6. Porter’s Analysis 4.7. PESTEL analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Market Outlook 5.1.3. Per Capita Healthcare Spending Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Product Adoption Rate and Demand 5.2.3. New Product Launches 5.2.4. Increase in Demand for Non-invasive Surgeries 5.2.5. Changing Regulatory Dynamics 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.2. 2021 Market Scenario 7. Global Gastric Space-Occupying Devices Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032 7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Gastric Space-Occupying Devices Market Pricing Analysis 8.1. Regional Pricing Analysis, By Product 8.2. Global Average Pricing Analysis Benchmark 8.3. Pricing Assumptions 9. Global Gastric Space-Occupying Devices Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032 9.1. Historical Market Volume (Units) Analysis, 2017–2021, By Product 9.2. Current and Future Market Volume (Units) Projections, 2022–2032, By Product 9.2.1. Y-o-Y Growth Trend Analysis 10. Global Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032, by Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Product, 2017–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022–2032 10.3.1. Gastric Balloons 10.3.2. Oral Palatal Space Occupying Devices 10.4. Market Attractiveness Analysis By Product 11. Global Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 11.3.1. Hospitals 11.3.2. Specialty Clinics 11.3.3. Ambulatory Surgical Centers 11.4. Market Attractiveness Analysis By End User 12. Global Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis, By Region, 2017–2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 13.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By End User 13.5. Market Trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country Level Analysis & Forecast 13.8.1. U.S. Gastric Space-Occupying Devices Market 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Product 13.8.1.2.2. By End User 13.8.2. Canada Gastric Space-Occupying Devices Market 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Product 13.8.2.2.2. By End User 14. Latin America Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 14.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By End User 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. Brazil Gastric Space-Occupying Devices Market 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Product 14.8.1.2.2. By End User 14.8.2. Argentina Gastric Space-Occupying Devices Market 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Product 14.8.2.2.2. By End User 14.8.3. Mexico Gastric Space-Occupying Devices Market 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Product 14.8.3.2.2. By End User 15. Europe Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 15.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. BENELUX 15.3.1.7. Russia 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By End User 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. Germany Gastric Space-Occupying Devices Market 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By End User 15.8.2. France Gastric Space-Occupying Devices Market 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By End User 15.8.3. Italy Gastric Space-Occupying Devices Market 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Product 15.8.3.2.2. By End User 15.8.4. Spain Gastric Space-Occupying Devices Market 15.8.4.1. Introduction 15.8.4.2. Market Analysis and Forecast by Market Taxonomy 15.8.4.2.1. By Product 15.8.4.2.2. By End User 15.8.5. U.K. Gastric Space-Occupying Devices Market 15.8.5.1. Introduction 15.8.5.2. Market Analysis and Forecast by Market Taxonomy 15.8.5.2.1. By Product 15.8.5.2.2. By End User 15.8.6. Benelux Union Gastric Space-Occupying Devices Market 15.8.6.1. Introduction 15.8.6.2. Market Analysis and Forecast by Market Taxonomy 15.8.6.2.1. By Product 15.8.6.2.2. By End User 15.8.7. Russia Gastric Space-Occupying Devices Market 15.8.7.1. Introduction 15.8.7.2. Market Analysis and Forecast by Market Taxonomy 15.8.7.2.1. By Product 15.8.7.2.2. By End User 16. South Asia Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 16.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By End User 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. India Gastric Space-Occupying Devices Market 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By End User 16.8.2. Indonesia Gastric Space-Occupying Devices Market 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By End User 16.8.3. Thailand Gastric Space-Occupying Devices Market 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By End User 16.8.4. Malaysia Gastric Space-Occupying Devices Market 16.8.4.1. Introduction 16.8.4.2. Market Analysis and Forecast by Market Taxonomy 16.8.4.2.1. By Product 16.8.4.2.2. By End User 16.8.4.2.3. By End User 17. East Asia Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 17.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By End User 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. China Gastric Space-Occupying Devices Market 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By End User 17.8.2. Japan Gastric Space-Occupying Devices Market 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By End User 17.8.3. South Korea Gastric Space-Occupying Devices Market 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By End User 18. Oceania Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 18.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By End User 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. Australia Gastric Space-Occupying Devices Market 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By End User 18.8.2. New Zealand Gastric Space-Occupying Devices Market 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By End User 19. Middle East and Africa (MEA) Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 19.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Turkey 19.3.1.3. North Africa 19.3.1.4. South Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By End User 19.5. Market Trends 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country Level Analysis & Forecast 19.8.1. GCC Countries Gastric Space-Occupying Devices Market 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By End User 19.8.2. Turkey Gastric Space-Occupying Devices Market 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By End User 19.8.3. South Africa Gastric Space-Occupying Devices Market 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By End User 19.8.4. North Africa Gastric Space-Occupying Devices Market 19.8.4.1. Introduction 19.8.4.2. Market Analysis and Forecast by Market Taxonomy 19.8.4.2.1. By Product 19.8.4.2.2. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players 20.3. Technology Footprint 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep Dive 21.3.1.1. Apollo Endosurgery, Inc. 21.3.1.1.1. Overview 21.3.1.1.2. Product Portfolio 21.3.1.1.3. Key Financials 21.3.1.1.4. SWOT Analysis 21.3.1.1.5. Sales Footprint 21.3.1.1.6. Key Developments 21.3.1.1.7. Strategy Overview 21.3.1.2. Obalon Therapeutics, Inc. 21.3.1.2.1. Overview 21.3.1.2.2. Product Portfolio 21.3.1.2.3. Key Financials 21.3.1.2.4. SWOT Analysis 21.3.1.2.5. Sales Footprint 21.3.1.2.6. Key Developments 21.3.1.2.7. Strategy Overview 21.3.1.3. Allurion Technologies, Inc. 21.3.1.3.1. Overview 21.3.1.3.2. Product Portfolio 21.3.1.3.3. Key Financials 21.3.1.3.4. SWOT Analysis 21.3.1.3.5. Sales Footprint 21.3.1.3.6. Key Developments 21.3.1.3.7. Strategy Overview 21.3.1.4. Helioscopie 21.3.1.4.1. Overview 21.3.1.4.2. Product Portfolio 21.3.1.4.3. Key Financials 21.3.1.4.4. SWOT Analysis 21.3.1.4.5. Sales Footprint 21.3.1.4.6. Key Developments 21.3.1.4.7. Strategy Overview 21.3.1.5. Endalis 21.3.1.5.1. Overview 21.3.1.5.2. Product Portfolio 21.3.1.5.3. Key Financials 21.3.1.5.4. SWOT Analysis 21.3.1.5.5. Sales Footprint 21.3.1.5.6. Key Developments 21.3.1.5.7. Strategy Overview 21.3.1.6. MEDSIL 21.3.1.6.1. Overview 21.3.1.6.2. Product Portfolio 21.3.1.6.3. Key Financials 21.3.1.6.4. SWOT Analysis 21.3.1.6.5. Sales Footprint 21.3.1.6.6. Key Developments 21.3.1.6.7. Strategy Overview 21.3.1.7. ReShape Medical, Inc. 21.3.1.7.1. Overview 21.3.1.7.2. Product Portfolio 21.3.1.7.3. Key Financials 21.3.1.7.4. SWOT Analysis 21.3.1.7.5. Sales Footprint 21.3.1.7.6. Key Developments 21.3.1.7.7. Strategy Overview 21.3.1.8. Lexel Medical 21.3.1.8.1. Overview 21.3.1.8.2. Product Portfolio 21.3.1.8.3. Key Financials 21.3.1.8.4. SWOT Analysis 21.3.1.8.5. Sales Footprint 21.3.1.8.6. Key Developments 21.3.1.8.7. Strategy Overview 21.3.1.9. Scientific Intake 21.3.1.9.1. Overview 21.3.1.9.2. Product Portfolio 21.3.1.9.3. Key Financials 21.3.1.9.4. SWOT Analysis 21.3.1.9.5. Sales Footprint 21.3.1.9.6. Key Developments 21.3.1.9.7. Strategy Overview 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Gastric Space-Occupying Devices Market
